首页 | 本学科首页   官方微博 | 高级检索  
     


Bleeding‐related hospital admissions and 30‐day readmissions in patients with non‐valvular atrial fibrillation treated with dabigatran versus warfarin
Authors:W. C. Y. Lau  X. Li  I. C. K. Wong  K. K. C. Man  G. Y. H. Lip  W. K. Leung  C. W. Siu  E. W. Chan
Affiliation:1. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong;2. Research Department of Practice and Policy, UCL School of Pharmacy, London, UK;3. Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong;4. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK;5. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;6. Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Abstract:
Keywords:anticoagulant  atrial fibrillation  bleeding  dabigatran  readmission  warfarin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号